Literature DB >> 8225604

Two different types of ADP-ribosyltransferase C3 from Clostridium botulinum type D lysogenized organisms.

K Moriishi1, B Syuto, M Saito, K Oguma, N Fujii, N Abe, M Naiki.   

Abstract

We examined production of ADP-ribosyltransferase C3 in 11 strains of Clostridium botulinum type C and D and their nontoxigenic derivatives. Antisera to C3 proteins of type C organisms divided C3 proteins roughly into at least two groups, bearing no relation to their bacterial types. The C3 gene of type D strain South African was isolated from a toxigenic phage library, and the complete sequence of the C3 gene was determined. The C3 protein of type D strain South African had 98% homology to the C3 protein of type C strain 003-9 and 66% homology to that of type D strain 1873. These results indicate that there are two types of C3 protein in type D organisms, as there are in type C organisms.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8225604      PMCID: PMC281316          DOI: 10.1128/iai.61.12.5309-5314.1993

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Purification and characterization of an ADP-ribosyltransferase produced by Clostridium limosum.

Authors:  I Just; C Mohr; G Schallehn; L Menard; J R Didsbury; J Vandekerckhove; J van Damme; K Aktories
Journal:  J Biol Chem       Date:  1992-05-25       Impact factor: 5.157

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  Biochemical classification of Clostridium botulinum type C and D strains and their nontoxigenic derivatives.

Authors:  K Oguma; T Yamaguchi; K Sudou; N Yokosawa; Y Fujikawa
Journal:  Appl Environ Microbiol       Date:  1986-02       Impact factor: 4.792

4.  The origin, structure, and pharmacological activity of botulinum toxin.

Authors:  L L Simpson
Journal:  Pharmacol Rev       Date:  1981-09       Impact factor: 25.468

5.  Functional modification of a 21-kilodalton G protein when ADP-ribosylated by exoenzyme C3 of Clostridium botulinum.

Authors:  E J Rubin; D M Gill; P Boquet; M R Popoff
Journal:  Mol Cell Biol       Date:  1988-01       Impact factor: 4.272

6.  Isolation and molecular size of Clostridium botulinum type C toxin.

Authors:  B Syuto; S Kubo
Journal:  Appl Environ Microbiol       Date:  1977-02       Impact factor: 4.792

7.  Botulinum ADP-ribosyltransferase C3 but not botulinum neurotoxins C1 and D ADP-ribosylates low molecular mass GTP-binding proteins.

Authors:  S Rösener; G S Chhatwal; K Aktories
Journal:  FEBS Lett       Date:  1987-11-16       Impact factor: 4.124

8.  Phage conversion to hemagglutinin production in Clostridium botulinum types C and D.

Authors:  K Oguma; H Iida; M Shiozaki
Journal:  Infect Immun       Date:  1976-09       Impact factor: 3.441

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  ADP-ribosylation of a 21-24 kDa eukaryotic protein(s) by C3, a novel botulinum ADP-ribosyltransferase, is regulated by guanine nucleotide.

Authors:  K Aktories; J Frevert
Journal:  Biochem J       Date:  1987-10-15       Impact factor: 3.857

View more
  5 in total

Review 1.  Phages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversion.

Authors:  Harald Brüssow; Carlos Canchaya; Wolf-Dietrich Hardt
Journal:  Microbiol Mol Biol Rev       Date:  2004-09       Impact factor: 11.056

Review 2.  The family of bacterial ADP-ribosylating exotoxins.

Authors:  K M Krueger; J T Barbieri
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

3.  Molecular Evolutionary Constraints that Determine the Avirulence State of Clostridium botulinum C2 Toxin.

Authors:  A Prisilla; R Prathiviraj; P Chellapandi
Journal:  J Mol Evol       Date:  2017-04-05       Impact factor: 2.395

Review 4.  Botulinum toxins--cause of botulism and systemic diseases?

Authors:  H Böhnel; F Gessler
Journal:  Vet Res Commun       Date:  2005-05       Impact factor: 2.459

5.  Molecular cloning of the gene encoding the mosaic neurotoxin, composed of parts of botulinum neurotoxin types C1 and D, and PCR detection of this gene from Clostridium botulinum type C organisms.

Authors:  K Moriishi; M Koura; N Fujii; Y Fujinaga; K Inoue; B Syuto; K Oguma
Journal:  Appl Environ Microbiol       Date:  1996-02       Impact factor: 4.792

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.